Suppr超能文献

伊朗亚兹德地区糖尿病患者启动胰岛素治疗的障碍。

The barriers against initiating insulin therapy among patients with diabetes living in Yazd, Iran.

作者信息

Shafie Pour M R, Sadeghiyeh T, Hadavi M, Besharati M, Bidaki R

机构信息

Department of Internal Medicine, Rafsanjan University of Medical Sciences, Rafsanjan, Iran.

Department of Psychiatry, Research Center of Addiction and Behavioral Sciences, Hahid Sadoughi University of Medical Sciences, Yazd, Iran.

出版信息

Diabetes Metab Syndr Obes. 2019 Aug 7;12:1349-1354. doi: 10.2147/DMSO.S200867. eCollection 2019.

Abstract

INTRODUCTION

The decision to start insulin therapy is often difficult. Determining the barriers against insulin therapy initiation can facilitate care and treatment strategies. The aim of this study was to evaluate the barriers against initiating insulin therapy among patients with diabetes living in Yazd, Iran.

METHODS

This descriptive study was conducted on 214 patients referred to the Diabetes Center of Yazd University of Medical Sciences in 2015. Participants were randomly selected, and then they completed the insulin noncompliance questionnaire (20 questions). The percentage of adherence and the factors contributing to nonadherence to insulin therapy were analyzed using descriptive statistics, the Kruskal-Wallis test, and the Mann-Whitney test.

RESULTS

The most prevalent reason for insulin therapy refusal was expecting a new method of diabetes treatment (54.7%), followed by requiring someone else to administer the injection (19.2%), fear of needles, cost, traveling (18.7%), and stress/emotional problems (18.2%). Lack of trust in the physician was the least restrictive reason for nonadherence to insulin therapy.

CONCLUSION

The most common reason given for insulin therapy refusal was the lack of adequate education. Therefore, specialized educational interventions can help minimize barriers and improve patients' outcomes.

摘要

引言

开始胰岛素治疗的决定往往很困难。确定胰岛素治疗起始的障碍有助于制定护理和治疗策略。本研究的目的是评估伊朗亚兹德地区糖尿病患者开始胰岛素治疗的障碍。

方法

本描述性研究于2015年对转诊至亚兹德医科大学糖尿病中心的214名患者进行。参与者被随机选取,然后完成胰岛素治疗依从性问卷(20个问题)。使用描述性统计、Kruskal-Wallis检验和Mann-Whitney检验分析胰岛素治疗的依从率和导致不依从的因素。

结果

拒绝胰岛素治疗最常见的原因是期待新的糖尿病治疗方法(54.7%),其次是需要他人注射(19.2%)、害怕打针、费用、出行(18.7%)以及压力/情绪问题(18.2%)。对医生缺乏信任是胰岛素治疗不依从最不具限制性的原因。

结论

拒绝胰岛素治疗最常见的原因是缺乏充分的教育。因此,专门的教育干预有助于减少障碍并改善患者的治疗效果。

相似文献

1
The barriers against initiating insulin therapy among patients with diabetes living in Yazd, Iran.
Diabetes Metab Syndr Obes. 2019 Aug 7;12:1349-1354. doi: 10.2147/DMSO.S200867. eCollection 2019.
2
Factors affecting the choice of treatment center by infertile couples: A cross-sectional study in Yazd Reproductive Sciences Institute.
Int J Reprod Biomed. 2023 Nov 24;21(10):827-834. doi: 10.18502/ijrm.v21i10.14538. eCollection 2023 Oct.
3
Barriers of Doctors and Patients in Starting Insulin for Type 2 Diabetes Mellitus.
Cureus. 2021 Sep 25;13(9):e18263. doi: 10.7759/cureus.18263. eCollection 2021 Sep.
4
Data on insulin therapy refusal among type II diabetes mellitus patients in Mashhad, Iran.
Data Brief. 2018 May 4;18:2047-2050. doi: 10.1016/j.dib.2018.04.136. eCollection 2018 Jun.
6
Comparing the quality of life in insulin recipient and refusal patients with type 2 diabetes.
Iran J Nurs Midwifery Res. 2016 Jul-Aug;21(4):351-6. doi: 10.4103/1735-9066.185571.
8
Reason for refusal of insulin therapy among type 2 diabetes mellitus patients in primary care clinic in Bangalore.
J Family Med Prim Care. 2020 Feb 28;9(2):854-858. doi: 10.4103/jfmpc.jfmpc_973_19. eCollection 2020 Feb.
10
Overcoming patient barriers to initiating insulin therapy in type 2 diabetes mellitus.
Clin Cornerstone. 2008;9(2):63-70; discussion 71-3. doi: 10.1016/s1098-3597(09)62041-x.

引用本文的文献

1
Challenges to Lifestyle Medicine for Type 2 Diabetes in Iran: A Synoptic Review.
Am J Lifestyle Med. 2023 Apr 3;19(4):534-547. doi: 10.1177/15598276231167787. eCollection 2025 May-Jun.
4
Assessing Barriers to Insulin Therapy among Omani Diabetic Patients Attending Three Main Diabetes Clinics in Muscat, Oman.
Sultan Qaboos Univ Med J. 2022 Nov;22(4):525-531. doi: 10.18295/squmj.6.2021.086. Epub 2022 Nov 7.
5
Barriers and Facilitators in Access to Diabetes, Hypertension, and Dyslipidemia Medicines: A Scoping Review.
Public Health Rev. 2022 Sep 2;43:1604796. doi: 10.3389/phrs.2022.1604796. eCollection 2022.
7
The prevalence and evidence-based management of needle fear in adults with chronic disease: A scoping review.
PLoS One. 2021 Jun 10;16(6):e0253048. doi: 10.1371/journal.pone.0253048. eCollection 2021.

本文引用的文献

2
Data on insulin therapy refusal among type II diabetes mellitus patients in Mashhad, Iran.
Data Brief. 2018 May 4;18:2047-2050. doi: 10.1016/j.dib.2018.04.136. eCollection 2018 Jun.
4
Psychological Insulin Resistance in Patients with Type 2 Diabetes.
J Assoc Physicians India. 2015 Jul;63(7):33-9.
6
Insulin adherence in patients with diabetes: risk factors for injection omission.
Prim Care Diabetes. 2014 Dec;8(4):338-45. doi: 10.1016/j.pcd.2014.03.001. Epub 2014 Apr 8.
7
Insulin administration and the impacts of forgetting a dose.
Patient. 2014;7(1):63-71. doi: 10.1007/s40271-013-0029-9.
10
Barriers to insulin progression among patients with type 2 diabetes: a systematic review.
Diabetes Educ. 2013 Jan-Feb;39(1):53-65. doi: 10.1177/0145721712467696. Epub 2012 Nov 27.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验